Avedian Raises USD 2.2M led by Meet Capital, to Accelerate Its Global Healthtech Expansion
Avedian raises USD 2.2M to scale its AI-powered healthcare platforms globally, expand into the U.S., and strengthen its data-driven solutions for providers and insurers.
Avedian has taken a major step forward in its international growth strategy after closing a USD 2.2 million investment round, marking one of the most significant milestones in the company’s evolution. The funding was led by Meet Capital, alongside angel investors from the healthcare sector and a family office, strengthening the company’s path toward scaling its AI-driven solutions.
A Startup Rooted in a Family Legacy of Healthcare Innovation
Founded in Córdoba in 2017 by brothers Guillermo, Pablo, and Facundo Tabares, Avedian builds on a deep family history in healthcare spanning three generations. Their grandfather, Oscar Martínez Soto, established Sanatorio Parque in 1971 and later launched the health insurer Parque Salud in 1994.
Today, CEO and surgeon Guillermo Tabares, CFO and accountant Facundo Tabares, and COO and lawyer Pablo Tabares lead a team of 45 professionals, all graduates of the National University of Córdoba.
“We grew up inside a hospital and a prepaid medicine company. We saw firsthand how clinical and financial decisions were made,” Guillermo explains. “That experience convinced us that technology can unlock the bottlenecks that keep the healthcare system from being efficient.”
AI-Driven Solutions to Transform Healthcare Operations
Avedian focuses on tackling the fragmentation and underutilization of clinical, financial, and operational data. According to its founders, the startup’s platforms turn this dispersed information into actionable insights that help providers and payers take more informed decisions.
The company operates two main platforms:
Both incorporate modules for:
- Clinical management, including bed optimization and predictive models for patient evolution
- Economic management, covering cost control, medical auditing, productivity, and fee settlement
- Commercial management, addressing pricing, contracts, and negotiations
- Data governance, value-based contracting, payment models tied to outcomes, and risk-sharing agreements for medication access
By centralizing unstructured and fragmented datasets, from affiliation systems to medical auditing and billing, Avedian’s technology enables predictive analytics, pattern identification, and more efficient care coordination.
Measurable Impact and Growing Client Portfolio
The company reports promising results:
- Up to 30% improvement in bed availability
- Up to 40% increase in revenue
- A 25% reduction in average length of stay
- A 20% decrease in costs tied to poor quality
“These tools anticipate complications, personalize care, and help health systems operate more efficiently,” says Guillermo.
Avedian’s solutions are currently used by clients such as Apross (Argentina), Keralty (Colombia), ARS Primera (Dominican Republic), and RIMAC Seguros (Peru). The company surpassed USD 2 million in revenue in 2024.
A Strategic Investment for International Expansion
Equitum and Capitus served as financial advisors, structuring and executing the fundraising process. Beyond capital, Avedian also secured a major new milestone: a distribution agreement with one of the world’s leading hospitals, based in the United States. Though the institution remains unnamed, it oversees a global network of 90 health systems.
Through this agreement, Avedian’s platforms will be distributed across China, India, Saudi Arabia, Switzerland, Mexico, and Southeast Asia, setting the stage for accelerated global deployment.
The new funding will be directed toward expansion in the United States, Spain, and Latin America, as well as strengthening the data science and engineering teams and advancing strategic partnerships. “This is smart capital—it brings money, but also access, experience, and networks,” Guillermo notes.
Meet Capital’s managing partner, Gabriel Florensa, emphasizes the importance of the U.S. market: “This round is primarily aimed at the company’s entry into the American market, which will be resource-intensive but also represents a major opportunity for globalizing the company.”
A Rapidly Growing Market for AI in Healthcare
Avedian is entering a segment with strong momentum: artificial intelligence for healthcare is projected to grow at a 37% CAGR, according to Market Research Future (2023).
“Health systems need more efficiency, and AI is no longer the future—it’s the present,” Guillermo concludes.
